Carruthers Wendy's Form 4 filing
Boston Scientific Corp (BSX) · filed Dec 18, 2023
- Accession no.
- 0001225208-23-011206
- Filed
- Dec 18, 2023
- Trade date
- Dec 15, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $649.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carruthers WendyCIK 0001563565 | Officer (EVP, Human Resources) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Common Stock | MOption exerciseAcquired | +3,450 | $16.31 | +$56,269.5 | 49,982 | Direct | |
| Dec 15, 2023 | Common Stock | MOption exerciseAcquired | +2,959 | $13.08 | +$38,703.72 | 52,941 | Direct | |
| Dec 15, 2023 | Common Stock | SSaleDisposed | −11,672 | $55.61F2 | −$649,079.92 | 41,269 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Common Stock | MOption exerciseDisposed | −3,450 | $0.00 | $0 | 0 | Direct | |
| Dec 15, 2023 | Common Stock | MOption exerciseDisposed | −2,959 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $55.11 to $56.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.